Ming-Ru Wu

1.1k total citations
18 papers, 837 citations indexed

About

Ming-Ru Wu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ming-Ru Wu has authored 18 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Ming-Ru Wu's work include CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (6 papers) and CRISPR and Genetic Engineering (5 papers). Ming-Ru Wu is often cited by papers focused on CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (6 papers) and CRISPR and Genetic Engineering (5 papers). Ming-Ru Wu collaborates with scholars based in United States, Taiwan and Israel. Ming-Ru Wu's co-authors include Charles L. Sentman, Tong Zhang, Marie-Louise Sentman, Paul W. Spear, Timothy K. Lu, Barbara Jusiak, Lior Nissim, Doron Stupp, Yuval Tabach and Hiroshi Suzuki and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ming-Ru Wu

17 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Ru Wu United States 12 423 359 349 142 121 18 837
Naveen K. Mehta United States 12 530 1.3× 616 1.7× 380 1.1× 215 1.5× 86 0.7× 26 991
Zhenqing Feng China 14 368 0.9× 204 0.6× 261 0.7× 72 0.5× 84 0.7× 26 674
John S. Bridgeman United Kingdom 17 701 1.7× 664 1.8× 341 1.0× 224 1.6× 175 1.4× 36 1.2k
Nicole Berndt Germany 17 461 1.1× 367 1.0× 275 0.8× 204 1.4× 89 0.7× 34 798
Alba Rodríguez-García United States 13 637 1.5× 385 1.1× 283 0.8× 181 1.3× 245 2.0× 17 876
Glenn Goetgeluk Belgium 13 250 0.6× 265 0.7× 185 0.5× 153 1.1× 71 0.6× 17 539
Noor Momin United States 13 632 1.5× 648 1.8× 354 1.0× 226 1.6× 101 0.8× 24 1.1k
Matthew Tiffany United States 10 241 0.6× 244 0.7× 327 0.9× 100 0.7× 152 1.3× 15 678
Ranjan Upadhyay United States 7 358 0.8× 392 1.1× 151 0.4× 84 0.6× 52 0.4× 12 582

Countries citing papers authored by Ming-Ru Wu

Since Specialization
Citations

This map shows the geographic impact of Ming-Ru Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Ru Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Ru Wu more than expected).

Fields of papers citing papers by Ming-Ru Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Ru Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Ru Wu. The network helps show where Ming-Ru Wu may publish in the future.

Co-authorship network of co-authors of Ming-Ru Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Ru Wu. A scholar is included among the top collaborators of Ming-Ru Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Ru Wu. Ming-Ru Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhu, Bo, et al.. (2024). Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy. Cellular and Molecular Immunology. 21(5). 436–447. 15 indexed citations
2.
Wang, Yufei, Alicia Buck, Brandon Piel, et al.. (2023). 442 CAIX targeted CAR-T cells exhibited antitumor efficacy on renal cell carcinoma (RCC) patient derived organotypic tumor spheroids (PDOTS). SHILAP Revista de lepidopterología. A491–A491. 1 indexed citations
3.
Kim, Hyeonkyeong, Martin Hemberg, Ming-Ru Wu, et al.. (2023). Decoupling NAD+ metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2α axis. Cell Reports Medicine. 5(1). 101342–101342. 3 indexed citations
4.
Chen, Chien‐Wen, Leonid Gaidukov, Yong Lai, et al.. (2022). A synthetic transcription platform for programmable gene expression in mammalian cells. Nature Communications. 13(1). 6167–6167. 19 indexed citations
5.
Wu, Ming-Ru, Lior Nissim, Doron Stupp, et al.. (2019). A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS). Nature Communications. 10(1). 2880–2880. 51 indexed citations
6.
Wu, Ming-Ru, Barbara Jusiak, & Timothy K. Lu. (2019). Engineering advanced cancer therapies with synthetic biology. Nature reviews. Cancer. 19(4). 187–195. 69 indexed citations
7.
Cao, Jicong, Pablo Pérez‐Piñera, Ky Lowenhaupt, et al.. (2018). Versatile and on-demand biologics co-production in yeast. Nature Communications. 9(1). 77–77. 26 indexed citations
8.
Nissim, Lior, Ming-Ru Wu, Hiroshi Suzuki, et al.. (2017). Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy. Cell. 171(5). 1138–1150.e15. 117 indexed citations
9.
Wu, Ming-Ru, et al.. (2017). Effects of particle shape and temperature on compaction of copper powder at micro scale. SHILAP Revista de lepidopterología. 123. 11–11.
10.
Lee, Gyudo, Lior Atia, Bo Lan, et al.. (2017). Contact guidance and collective migration in the advancing epithelial monolayer. Connective Tissue Research. 59(4). 309–315. 10 indexed citations
11.
Sentman, Marie-Louise, Joana Murad, W. James Cook, et al.. (2016). Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice. The Journal of Immunology. 197(12). 4674–4685. 49 indexed citations
12.
Wu, Ming-Ru, et al.. (2015). B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity. The Journal of Immunology. 194(11). 5305–5311. 53 indexed citations
13.
Wu, Ming-Ru, Tong Zhang, Andre Alcon, & Charles L. Sentman. (2014). DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma. Cancer Immunology Immunotherapy. 64(4). 409–418. 32 indexed citations
14.
Wu, Ming-Ru, W. James Cook, Tong Zhang, & Charles L. Sentman. (2014). Targeting multiple types of tumors using NKG2D-coated iron oxide nanoparticles. Nanotechnology. 25(47). 475101–475101. 4 indexed citations
15.
Spear, Paul W., Ming-Ru Wu, Marie-Louise Sentman, & Charles L. Sentman. (2013). NKG2D ligands as therapeutic targets.. PubMed. 13. 8–8. 204 indexed citations
16.
Zhang, Tong, Ming-Ru Wu, & Charles L. Sentman. (2012). An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo. The Journal of Immunology. 189(5). 2290–2299. 114 indexed citations
17.
Lee, Hyun, Chunhua Yuan, Andrew Hammet, et al.. (2008). Diphosphothreonine-Specific Interaction between an SQ/TQ Cluster and an FHA Domain in the Rad53-Dun1 Kinase Cascade. Molecular Cell. 30(6). 767–778. 61 indexed citations
18.
Wu, Ming-Ru, et al.. (1998). Transorbital penetrating injury of the paranasal sinuses. The Journal of Laryngology & Otology. 112(12). 1202–1204. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026